National ANTIBIOTIC RESISTANCE Portal

Home • Practical info & communications • News

A Decrease font size. A Reset font size. A Increase font size.

News

Announcements of publications, patents, non-scientific articles, comments, announcements from departments, partners or industry

1 April 2021

CARB-X is funding university of Oxford’s Jenner Institute to develop a new vaccine to prevent gonorrhea

Actualités
France

Vaccine aims to curb the global spread of this devastating disease and strains of ‘super gonorrhea’ antibiotic-resistant bacteria Arcile published

31 March 2021

New ReAct report: Governments need to take more leadership to ensure global sustainable access to effective antibiotics

Actualités, Bilans, rapports et recommandations
International

Article published on the ReAct website on March 30, 2021.

30 March 2021

Leveraging Vaccines to Reduce Antibiotic Use and Prevent Antimicrobial Resistance, a World Health Organization strategy to articulate the role of vaccines against AMR

Actualités, Bilans, rapports et recommandations
International

Article published on January 27, 2021 on the World Health Organization website. WHO has develo ...

29 March 2021

FAO Assessment Tool for Laboratories and AMR Surveillance Systems (FAO-ATLASS)

Actualités, Bilans, rapports et recommandations
International

Towards global surveillance of Antimicrobial Resistance Article published on the FAO website.

29 March 2021

International instruments on the use of antimicrobials across the human, animal and plant sectors, a FAO, WHO and OIE report

Actualités, Bilans, rapports et recommandations
International

The publication International instruments on the use of antimicrobials across the human, animal and plant sectorswas developed by the Tripartite organizations: the Food and Agriculture Organization of the United Nations (FAO), the

18 March 2021

Pherecydes Pharma : le projet de production de phages (PhagoPROD) de Pherecydes Pharma à l’honneur dans le magazine CORDIS de la Commission Européenne

Actualités

Article publié le 15 mars 2021 sur Zonebourse.com 15/03/2021 | 17:46

18 March 2021

Treatment of patients with Staph aureus bloodstream infections: ContraFect announces Barda contract award for up to $86.8 million

Actualités
International

Article published on March 11, 2021, on the ContraFect website. BARDA to provide funding for the ongoing Ph ...

16 March 2021

NIH awards grants to support bacteriophage therapy research

Actualités
International

“Phage” therapies offer potential strategy to combat antibacterial resistance. Article published on the National Institute of Health website on March 11, 2021 (in the

10 March 2021

CARB-X is funding the biotech Affinivax, to develop a new vaccine that will prevent Staphylococcus aureus bacterial infections

Actualités
International

Affinivax award could be worth up to $3.5 million, plus up to $18.5 million more if the project is successful through pre-clinical development and Phase 1:

8 March 2021

Results JPIAMR Network Plus call 2020

Actualités
France

Seven networks including 146 partners from 35 countries have been recommended for funding within the JPIAMR 10th transnational call: “JPIAMR Network Plus 2020”. The total funding amount is approx. 737.000 €. The call was launched in February 2020 and suppo ...

Cookies

This website uses cookies to improve your experience when browsing the website. Of these cookies, the cookies categorized as necessary are stored on your browser as they are essential for the functioning of basic website functionality. We also use third-party cookies which help us analyze and understand how you use this website. These cookies will only be stored in your browser with your consent. You also have the option of deactivating these cookies. But disabling some of these cookies may have an effect on your browsing experience.

Necessary

Always Enabled

Les cookies nécessaires sont absolument essentiels au bon fonctionnement du site Web. Cette catégorie comprend uniquement les cookies qui garantissent les fonctionnalités de base et les fonctionnalités de sécurité du site Web. Ces cookies ne stockent aucune information personnelle.

Cookie	Duration	Description
cookielawinfo-checkbox-necessary	11 mois	This cookie is set by the GDPR Cookie Consent plugin. Cookies are used to store user consent for cookies in the "Necessary" category.
cookielawinfo-checkbox-non-necessary	11 mois	This cookie is set by the GDPR Cookie Consent plugin. Cookies are used to store user consent for cookies in the "Not necessary" category.
cookielawinfo-checkbox-stats	1an	This cookie is set by the GDPR Cookie Consent plugin. The purpose of this cookie is to check whether or not the user has given his consent to the use of cookies in the “Statistics” category.
viewed_cookie_policy	11 mois	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not the user has consented to the use of cookies. It does not store any personal data.

Performance

Ils servent à collecter les informations sur l’utilisation du site, par exemple les pages que vous visitez, ou les messages d’erreur rencontrés. Ces cookies ne collectent aucune information permettant de vous identifier – toute l’information collectée est anonyme et n’est utilisée que dans le but d’améliorer le fonctionnement de notre site.

Cookie	Type	Duration	Description
_GPSLSC	0	4 minutes	This cookie is associated with a page speed script to improve the speed of the web page.

Statistics

Tous les cookies qui peuvent ne pas être particulièrement nécessaires au fonctionnement du site Web et qui sont utilisés spécifiquement pour collecter des données personnelles des utilisateurs via des analyses, des publicités et d’autres contenus intégrés sont appelés cookies non nécessaires. Il est obligatoire d’obtenir le consentement de l’utilisateur avant d’exécuter ces cookies sur votre site Web.